Wolverine Asset Management’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Wolverine Asset Management’s Portfolio AONCW Stock Details AONCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-41,559	Closed	-$14.1K	–	1853
2024 Q1	$14.1K	Sell	41,559 -7,146	-15%	-$2.03K	﹤0.01%	1250
2023 Q4	$11.2K	Buy	48,705 +6,682	+16%	+$1.4K	﹤0.01%	1371
2023 Q3	$6.93K	Buy	+42,023	New	+$9.72K	﹤0.01%	1526

Other funds holding AONCW

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $190M AUM 31.84% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Wolverine Asset Management's AONCW Position: Q2 2024 in Review

Wolverine Asset Management sold out of American Oncology Network, Inc. Warrant (AONCW) in Q2 2024, closing a stake of 41,559 shares — an estimated $14.1K sold.

Wolverine Asset Management first reported a position in AONCW in Q3 2023 and held it in 3 quarters. The position peaked at $14.1K in Q1 2024. 3 funds tracked by Wall St. Rank hold AONCW as of Q2 2024.

Wolverine Asset Management reported no remaining American Oncology Network, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
Wolverine Asset Management sold 41,559 American Oncology Network, Inc. Warrant shares in Q2 2024, an estimated $14.1K.
Wolverine Asset Management first reported a position in American Oncology Network, Inc. Warrant in Q3 2023 and held it in 3 quarters.
Wolverine Asset Management's American Oncology Network, Inc. Warrant position peaked at $14.1K in Q1 2024.
3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q2 2024.

Based on Wolverine Asset Management's 13F filing for Q2 2024, filed 1 Aug 2024.